FDA Inspection
ARUP Laboratories, Inc.ARUP Laboratories, Inc. – FDA Inspection, Nov 6, 2024
Record Details
This FDA Inspection record concerns ARUP Laboratories, Inc., with an inspection on November 6, 2024, issued by the Denver District Office, covering biologics.
View Company Profile
ID · 9cf1a2d5-4b6f-440f-9583-a10919d46d68
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1253895
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 211.68(b)input/output verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ARUP Laboratories, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 30, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 18, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 27, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 15, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 20, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ARUP Laboratories, Inc.
- FDA Inspection 1106104 - 2019-08-30
- FDA Inspection 998810 - 2017-01-18
- FDA Inspection 915709 - 2015-02-27
- FDA Inspection 825216 - 2013-02-15
- FDA Inspection 727928 - 2011-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.